{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:28:52Z","timestamp":1793820532923,"version":"4.6.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Research Foundation of Korea (NRF) grant funded by the Korean Government","award":["RS-2024-00347522"],"award-info":[{"award-number":["RS-2024-00347522"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Scientific Research Projects Coordination Unit of Istanbul University","award":["FDK-2024-40841"],"award-info":[{"award-number":["FDK-2024-40841"]}],"id":[{"id":"https:\/\/ror.org\/03a5qrr21","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11733-w","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:37:17Z","timestamp":1790170637000},"page":"11203-11226","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discovery of potent and selective MAO-B inhibitors from a morpholine-substituted chalcone library for neurodegenerative disorders"],"prefix":"10.1007","volume":"30","author":[{"given":"Asmar","family":"Taghiyeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeyeop","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abanish","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritika Uppal","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay N.","family":"Basavanakatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nil\u00fcfer","family":"Bayrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesan","family":"Jayaprakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Jeong","family":"Paik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ama\u00e7 Fatih","family":"TuYuN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"11733_CR1","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","volume":"124","author":"O Tysnes","year":"2017","unstructured":"Tysnes O, Storstein A (2017) Epidemiology of Parkinson\u2019s disease. J Neural Transm 124:901\u2013905","journal-title":"J Neural Transm"},{"key":"11733_CR2","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/jnc.13691","volume":"139","author":"S Sveinbjornsdottir","year":"2016","unstructured":"Sveinbjornsdottir S (2016) The clinical symptoms of Parkinson\u2019s disease. J Neurochem 139:318\u2013","journal-title":"J Neurochem"},{"issue":"1","key":"11733_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","volume":"36","author":"D Simon","year":"2020","unstructured":"Simon D, Tanner C, Brundin P (2020) Parkinson disease epidemiology, pathology, genetics, and pathophysiology. Clin Geriatr Med 36(1):1\u201312","journal-title":"Clin Geriatr Med"},{"key":"11733_CR4","first-page":"1","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland D, Batzu L, Halliday G, Geurtsen G, Ballard C, Chaudhuri R, Weintraub D (2021) Parkinson disease-associated cognitive impairment. Nat Rev Disease Primers 7:1\u201321","journal-title":"Nat Reviews Disease Primers"},{"key":"11733_CR5","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3390\/biom11101508","volume":"11","author":"A Picca","year":"2021","unstructured":"Picca A, Guerra F, Calvani R, Romano R, Coelho-J\u00fanior H, Bucci C, Marzetti E (2021) Mitochondrial dysfunction, protein misfolding and neuroinflammation in Parkinson\u2019s disease: roads to biomarker discovery. Biomolecules 11:1508","journal-title":"Biomolecules"},{"issue":"12","key":"11733_CR6","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.3390\/molecules26123724","volume":"26","author":"T Behl","year":"2021","unstructured":"Behl T, Kaur D, Sehgal A, Singh S, Sharma N, Zengin G, Andronie-Cioara FL, Toma MM, Bungau S, Bumbu AG (2021) Role of monoamine oxidase activity in Alzheimer\u2019s disease: an insight into the therapeutic potential of inhibitors. Molecules 26(12):3724","journal-title":"Molecules"},{"issue":"8","key":"11733_CR7","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.3390\/ijms23084453","volume":"23","author":"M-H Nam","year":"2022","unstructured":"Nam M-H, Sa M, Ju YH, Park MG, Lee CJ (2022) Revisiting the role of astrocytic MAOB in Parkinson\u2019s disease. Int J Mol Sci 23(8):4453","journal-title":"Int J Mol Sci"},{"key":"11733_CR8","doi-asserted-by":"publisher","first-page":"101256","DOI":"10.1016\/j.arr.2021.101256","volume":"66","author":"Y Santin","year":"2021","unstructured":"Santin Y, Resta J, Parini A, Mialet-Perez J (2021) Monoamine oxidases in age-associated diseases: new perspectives for old enzymes. Ageing Res Rev 66:101256","journal-title":"Ageing Res Rev"},{"issue":"11","key":"11733_CR9","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00702-018-1915-z","volume":"125","author":"LG Iacovino","year":"2018","unstructured":"Iacovino LG, Magnani F, Binda C (2018) The structure of monoamine oxidases: past, present, and future. J Neural Transm 125(11):1567\u20131579","journal-title":"J Neural Transm"},{"issue":"6","key":"11733_CR10","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/jcbfm.2013.19","volume":"33","author":"J Tong","year":"2013","unstructured":"Tong J, Meyer JH, Furukawa Y, Boileau I, Chang L-J, Wilson AA, Houle S (2013) Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies. J Cereb Blood Flow Metabolism 33(6):863\u2013871","journal-title":"J Cereb Blood Flow Metabolism"},{"key":"11733_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fnmol.2019.00143","volume":"12","author":"AWK Yeung","year":"2019","unstructured":"Yeung AWK, Georgieva MG, Atanasov AG, Tzvetkov NT (2019) Monoamine oxidases (MAOs) as privileged molecular targets in neuroscience: research literature analysis. Front Mol Neurosci 12:143","journal-title":"Front Mol Neurosci"},{"issue":"9","key":"11733_CR12","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1093\/brain\/awx172","volume":"140","author":"J Tong","year":"2017","unstructured":"Tong J, Rathitharan G, Meyer JH, Furukawa Y, Ang L-C, Boileau I, Guttman M, Hornykiewicz O, Kish SJ (2017) Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders. Brain 140(9):2460\u20132474","journal-title":"Brain"},{"issue":"1","key":"11733_CR13","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1021\/acs.jmedchem.0c01775","volume":"64","author":"E Viayna","year":"2021","unstructured":"Viayna E, Coquelle N, Cieslikiewicz-Bouet M, Cisternas P, Oliva CA, S\u00e1nchez-L\u00f3pez E, Ettcheto M, Bartolini M, De Simone A, Ricchini M, Rendina M, Pons M, Firuzi O, P\u00e9rez B, Saso L, Andrisano V, Nachon F, Brazzolotto X, Garc\u00eda ML, Camins A, Silman I, Jean L, Inestrosa NC, Colletier J-P, Renard P-Y (2021) Mu\u00f1oz-Torrero, discovery of a potent dual inhibitor of acetylcholinesterase and butyrylcholinesterase with antioxidant activity that alleviates Alzheimer-like pathology in old APP\/PS1 mice. J Med Chem 64(1):812\u2013839","journal-title":"J Med Chem"},{"issue":"6","key":"11733_CR14","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1016\/j.ejmech.2011.02.071","volume":"46","author":"B Tasso","year":"2011","unstructured":"Tasso B, Catto M, Nicolotti O, Novelli F, Tonelli M, Giangreco I, Pisani L, Sparatore A, Boido V, Carotti A, Sparatore F (2011) Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer\u2019s disease. Eur J Med Chem 46(6):2170\u20132184","journal-title":"Eur J Med Chem"},{"key":"11733_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3389\/fphar.2016.00340","volume":"7","author":"JPM Finberg","year":"2016","unstructured":"Finberg JPM, Rabey JM (2016) Inhibitors of MAO-A and MAO-B in psychiatry and neurology. Front Pharmacol 7:340","journal-title":"Front Pharmacol"},{"issue":"7suppl2","key":"11733_CR16","first-page":"S18","volume":"67","author":"C Caccia","year":"2006","unstructured":"Caccia C, Maj R, Calabresi M, Maestroni S, Faravelli L, Curatolo L, Salvati P, Fariello RG (2006) Safinamide. Neurol 67(7suppl2):S18\u2013S23","journal-title":"Safinamide Neurol"},{"key":"11733_CR17","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1016\/S1353-8020(08)70618-7","volume":"13","author":"C Caccia","year":"2007","unstructured":"Caccia C, Salvati P, Rossetti S, Anand R (2007) 2.207 Safinamide: beyond MAO-B inhibition. Parkinsonism Relat Disord 13:S99","journal-title":"Parkinsonism Relat Disord"},{"key":"11733_CR18","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3233\/JAD-161309","volume":"58","author":"S Nave","year":"2017","unstructured":"Nave S, Doody R, Boada M, Grimmer T, Savola J, Delmar P, Pauly-Evers M, Nikolcheva T, Czech C, Borroni E, Ricci B, Dukart J, Mannino M, Carey T, Moran E, Gilaberte I, Muelhardt NM, Gerlach I, Santarelli L, Ostrowitzki S, Fontoura P (2017) Sembragiline in moderate Alzheimer\u2019s disease: results of a randomized, double-blind, placebo-controlled Phase II trial (MAyflOwer RoAD). J Alzheimers Dis 58:1217\u20131228","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"11733_CR19","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1007\/s00415-017-8523-y","volume":"264","author":"E Cereda","year":"2017","unstructured":"Cereda E, Cilia R, Canesi M, Tesei S, Mariani CB, Zecchinelli AL, Pezzoli G (2017) Efficacy of rasagiline and selegiline in Parkinson\u2019s disease: a head-to-head 3-year retrospective case\u2013control study. J Neurol 264(6):1254\u20131263","journal-title":"J Neurol"},{"issue":"12P2","key":"11733_CR20","doi-asserted-by":"publisher","first-page":"174S","DOI":"10.1592\/phco.27.12part2.174S","volume":"27","author":"HH Fernandez","year":"2007","unstructured":"Fernandez HH, Chen JJ (2007) Monoamine oxidase-B inhibition in the treatment of Parkinson\u2019s disease. pharmacotherapy: J Hum Pharmacol Drug Therapy 27(12P2):174S\u2013185S","journal-title":"Pharmacotherapy: J Hum Pharmacol Drug Therapy"},{"issue":"17","key":"11733_CR21","doi-asserted-by":"publisher","first-page":"5480","DOI":"10.1016\/j.bmc.2013.05.066","volume":"21","author":"HR Park","year":"2013","unstructured":"Park HR, Kim J, Kim T, Jo S, Yeom M, Moon B, Choo IH, Lee J, Lim EJ, Park KD, Min S-J, Nam G, Keum G, Lee CJ, Choo H (2013) Oxazolopyridines and thiazolopyridines as monoamine oxidase B inhibitors for the treatment of Parkinson\u2019s disease. Bioorgan Med Chem 21(17):5480\u20135487","journal-title":"Bioorgan Med Chem"},{"key":"11733_CR22","doi-asserted-by":"publisher","first-page":"105203","DOI":"10.1016\/j.bioorg.2021.105203","volume":"115","author":"P Besada","year":"2021","unstructured":"Besada P, Vi\u00f1a D, Costas T, Costas-Lago MC, Vila N, Torres-Ter\u00e1n I, Sturlese M, Moro S, Ter\u00e1n C (2021) Pyridazinones containing dithiocarbamoyl moieties as a new class of selective MAO-B inhibitors. Bioorg Chem 115:105203","journal-title":"Bioorg Chem"},{"issue":"12","key":"11733_CR23","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.3390\/molecules27123801","volume":"27","author":"MA Alag\u00f6z","year":"2022","unstructured":"Alag\u00f6z MA, Oh JM, Zenni YN, \u00d6zdemir Z, Abdelgawad MA, Naguib IA, Ghoneim MM, Gambacorta N, Nicolotti O, Kim H, Mathew B (2022) Development of a novel class of pyridazinone derivatives as selective MAO-B inhibitors. Molecules 27(12):3801","journal-title":"Molecules"},{"issue":"7","key":"11733_CR24","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1021\/acschemneuro.7b00050","volume":"8","author":"M-H Nam","year":"2017","unstructured":"Nam M-H, Park M, Park H, Kim Y, Yoon S, Sawant VS, Choi JW, Park J-H, Park KD, Min S-J, Lee CJ, Choo H (2017) Indole-substituted benzothiazoles and benzoxazoles as selective and reversible MAO-B inhibitors for treatment of Parkinson\u2019s disease. ACS Chem Neurosci 8(7):1519\u20131529","journal-title":"ACS Chem Neurosci"},{"issue":"15","key":"11733_CR25","doi-asserted-by":"publisher","first-page":"6679","DOI":"10.1021\/jm500729a","volume":"57","author":"NT Tzvetkov","year":"2014","unstructured":"Tzvetkov NT, Hinz S, K\u00fcppers P, Gastreich M, M\u00fcller CE (2014) Indazole- and Indole-5-carboxamides: selective and reversible monoamine oxidase B inhibitors with subnanomolar potency. J Med Chem 57(15):6679\u20136703","journal-title":"J Med Chem"},{"key":"11733_CR26","doi-asserted-by":"publisher","first-page":"115352","DOI":"10.1016\/j.ejmech.2023.115352","volume":"255","author":"M Rullo","year":"2023","unstructured":"Rullo M, La Spada G, Miniero DV, Gottinger A, Catto M, Delre P, Mastromarino M, Latronico T, Marchese S, Mangiatordi GF, Binda C, Linusson A, Liuzzi GM, Pisani L (2023) Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors. Eur J Med Chem 255:115352","journal-title":"Eur J Med Chem"},{"issue":"23","key":"11733_CR27","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1021\/jm070677y","volume":"50","author":"C Binda","year":"2007","unstructured":"Binda C, Wang J, Pisani L, Caccia C, Carotti A, Salvati P, Edmondson DE, Mattevi A (2007) Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. J Med Chem 50(23):5848\u20135852","journal-title":"J Med Chem"},{"issue":"11","key":"11733_CR28","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1002\/cmdc.201600122","volume":"11","author":"B Mathew","year":"2016","unstructured":"Mathew B, Haridas A, U\u00e7ar G, Baysal I, Joy M, Mathew GE, Lakshmanan B, Jayaprakash V (2016) Synthesis, biochemistry, and computational studies of brominated thienyl chalcones: a new class of reversible MAO-B inhibitors. ChemMedChem 11(11):1161\u20131171","journal-title":"ChemMedChem"},{"key":"11733_CR29","doi-asserted-by":"publisher","first-page":"103335","DOI":"10.1016\/j.bioorg.2019.103335","volume":"93","author":"DGT Parambi","year":"2019","unstructured":"Parambi DGT, Oh JM, Baek SC, Lee JP, Tondo AR, Nicolotti O, Kim H, Mathew B (2019) Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors. Bioorg Chem 93:103335","journal-title":"Bioorg Chem"},{"issue":"9","key":"11733_CR30","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1021\/jm801590u","volume":"52","author":"F Chimenti","year":"2009","unstructured":"Chimenti F, Fioravanti R, Bolasco A, Chimenti P, Secci D, Rossi F, Y\u00e1\u00f1ez M, Orallo F, Ortuso F, Alcaro S (2009) Chalcones: a valid scaffold for monoamine oxidases inhibitors. J Med Chem 52(9):2818\u20132824","journal-title":"J Med Chem"},{"key":"11733_CR31","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.ejmech.2014.08.033","volume":"85","author":"P Singh","year":"2014","unstructured":"Singh P, Anand A, Kumar V (2014) Recent developments in biological activities of chalcones: a mini review. Eur J Med Chem 85:758\u2013777","journal-title":"Eur J Med Chem"},{"issue":"3","key":"11733_CR32","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1517\/13543776.2014.995627","volume":"25","author":"MJ Matos","year":"2015","unstructured":"Matos MJ, Vazquez-Rodriguez S, Uriarte E, Santana L (2015) Potential pharmacological uses of chalcones: a patent review (from June 2011\u20132014). Expert Opin Ther Pat 25(3):351\u2013366","journal-title":"Expert Opin Ther Pat"},{"issue":"2","key":"11733_CR33","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10311-019-00959-w","volume":"18","author":"A Rammohan","year":"2020","unstructured":"Rammohan A, Reddy JS, Sravya G, Rao CN, Zyryanov GV (2020) Chalcone synthesis, properties and medicinal applications: a review. Environ Chem Lett 18(2):433\u2013458","journal-title":"Environ Chem Lett"},{"key":"11733_CR34","doi-asserted-by":"publisher","first-page":"112650","DOI":"10.1016\/j.ejmech.2020.112650","volume":"205","author":"P Guglielmi","year":"2020","unstructured":"Guglielmi P, Mathew B, Secci D, Carradori S (2020) Chalcones: unearthing their therapeutic possibility as monoamine oxidase B inhibitors. Eur J Med Chem 205:112650","journal-title":"Eur J Med Chem"},{"key":"11733_CR35","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s11030-024-10959-w","volume":"29","author":"R Ipe","year":"2024","unstructured":"Ipe R, Oh J, Kumar S, Ahmad I, Nath L, Bindra S, Patel H, Kolachi K, Prabhakaran P, Gahtori P, Syed A, Elgorbanh A, Kim H, Mathew B (2024) Inhibition of monoamine oxidases and neuroprotective effects: chalcones vs. chromones. Mol Divers 29:2063\u20132079","journal-title":"Mol Divers"},{"key":"11733_CR36","doi-asserted-by":"publisher","first-page":"6908","DOI":"10.1021\/acsomega.2c07694","volume":"8","author":"S Kumar","year":"2023","unstructured":"Kumar S, Oh J, Abdelgawad M, Abourehab M, Tengli A, Singh AK, Ahmad I, Patel H, Mathew B, Kim H (2023) Development of isopropyl-tailed chalcones as a new class of selective MAO-B inhibitors for the treatment of Parkinson\u2019s disorder. ACS Omega 8:6908\u20136917","journal-title":"ACS Omega"},{"key":"11733_CR37","doi-asserted-by":"publisher","first-page":"5270","DOI":"10.1016\/j.bmcl.2015.09.049","volume":"25 22","author":"C Minders","year":"2015","unstructured":"Minders C, Petzer J, Petzer A, Lourens A (2015) Monoamine oxidase inhibitory activities of heterocyclic chalcones. Bioorg Med Chem Lett 25 22:5270\u20135276","journal-title":"Bioorg Med Chem Lett"},{"key":"11733_CR38","doi-asserted-by":"publisher","first-page":"103335","DOI":"10.1016\/j.bioorg.2019.103335","volume":"93","author":"D Parambi","year":"2019","unstructured":"Parambi D, Oh J, Baek S, Lee J, Tondo AR, Nicolotti O, Kim H, Mathew B (2019) Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors. Bioorg Chem 93:103335","journal-title":"Bioorg Chem"},{"key":"11733_CR39","doi-asserted-by":"crossref","unstructured":"Oh J, Rangarajan T, Chaudhary R, Singh R, Singh M, Singh R, Tondo AR, Gambacorta N, Nicolotti O, Mathew B, Kim H (2020) Novel class of chalcone oxime ethers as potent monoamine Oxidase-B and acetylcholinesterase inhibitors. Molecules 25","DOI":"10.3390\/molecules25102356"},{"key":"11733_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13765-023-00795-1","volume":"66","author":"A Krishna","year":"2023","unstructured":"Krishna A, Lee J, Kumar S, Sudevan S, Uniyal P, Pappachen L, Kim H, Mathew B (2023) Inhibition of monoamine oxidases by benzimidazole chalcone derivatives. Appl Biol Chem 66:1\u201310","journal-title":"Appl Biol Chem"},{"key":"11733_CR41","doi-asserted-by":"crossref","unstructured":"El-Damasy AK, Park JE, Kim HJ, Lee J, Bang EK, Kim H, Keum G (2023) Identification of New N-methyl-piperazine chalcones as dual MAO-B\/AChE inhibitors, Pharmaceuticals (Basel) 16(1)","DOI":"10.3390\/ph16010083"},{"key":"11733_CR42","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ejmech.2016.02.038","volume":"114","author":"A Hammuda","year":"2016","unstructured":"Hammuda A, Shalaby R, Rovida S, Edmondson DE, Binda C, Khalil A (2016) Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors. Eur J Med Chem 114:162\u2013169","journal-title":"Eur J Med Chem"},{"issue":"21","key":"11733_CR43","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1002\/slct.201901093","volume":"4","author":"B Lakshminarayanan","year":"2019","unstructured":"Lakshminarayanan B, Baek SC, Lee JP, Kannappan N, Mangiatordi GF, Nicolotti O, Subburaju T, Kim H, Mathew B (2019) Ethoxylated head of chalcones as a new class of multi-targeted MAO inhibitors. Chemistryselect 4(21):6614\u20136619","journal-title":"Chemistryselect"},{"issue":"8","key":"11733_CR44","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/ardp.201600088","volume":"349","author":"R Sasidharan","year":"2016","unstructured":"Sasidharan R, Manju SL, U\u00e7ar G, Baysal I, Mathew B (2016) Identification of indole-based chalcones: discovery of a potent, selective, and reversible class of MAO-B inhibitors. Arch Pharm 349(8):627\u2013637","journal-title":"Arch Pharm"},{"key":"11733_CR45","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.biopha.2018.06.064","volume":"106","author":"R Sasidharan","year":"2018","unstructured":"Sasidharan R, Baek SC, Sreedharannair Leelabaiamma M, Kim H, Mathew B (2018) Imidazole bearing chalcones as a new class of monoamine oxidase inhibitors. Biomed Pharmacother 106:8\u201313","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"11733_CR46","doi-asserted-by":"publisher","first-page":"1800309","DOI":"10.1002\/ardp.201800309","volume":"352","author":"B Mathew","year":"2019","unstructured":"Mathew B, Baek SC, Thomas Parambi DG, Lee JP, Mathew GE, Jayanthi S, Vinod D, Rapheal C, Devikrishna V, Kondarath SS, Uddin MS, Kim H (2019) Potent and highly selective dual-targeting monoamine oxidase-B inhibitors: fluorinated chalcones of morpholine versus imidazole. Arch Pharm 352(4):1800309","journal-title":"Arch Pharm"},{"issue":"8","key":"11733_CR47","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.2174\/1386207324666210603125452","volume":"25","author":"M Naseer","year":"2022","unstructured":"Naseer M, Ipek B, Anandkumar T, Gulberk U, Mohammad Ali Abdullah A, Della Grace Thomas P, Nicola G, Orazio N, Asmy Appadath B, Bijo M (2022) Trimethoxy crown chalcones as multifunctional class of monoamine oxidase enzyme inhibitors, combinatorial chemistry. High Throughput Screen 25(8):1314\u20131326","journal-title":"High Throughput Screen"},{"issue":"3","key":"11733_CR48","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/ph18030309","volume":"18","author":"D Choudhary","year":"2025","unstructured":"Choudhary D, Kumar B, Chandrasekaran B, Singh TG, Kaur R, Aldahish A, Vasudevan R, Balaji P (2025) Microwave-assisted synthesis of morpholine-based chalcones as reversible MAO-A inhibitors in the management of mental depression. Pharmaceuticals-Base 18(3):309","journal-title":"Pharmaceuticals-Base"},{"issue":"1","key":"11733_CR49","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13765-024-00857-y","volume":"67","author":"J Lee","year":"2024","unstructured":"Lee J, Parmbil SK, Pandit NK, Kumar S, Syed A, Elgorban AM, Wong LS, Ranjana H, Kim B, Mathew (2024) Development of morpholine ring-bearing halogenated \u03b1,\u03b2-unsaturated ketones as selective monoamine oxidase-B inhibitors. Appl Biol Chem 67(1):6","journal-title":"Appl Biol Chem"},{"key":"11733_CR50","doi-asserted-by":"publisher","first-page":"112273","DOI":"10.1016\/j.ejmech.2020.112273","volume":"201","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Min J, Chen M, Jiang X, Xu Y, Qin H, Tang W (2020) The structure-based optimization of \u03b4-sultone-fused pyrazoles as selective BuChE inhibitors. Eur J Med Chem 201:112273","journal-title":"Eur J Med Chem"},{"key":"11733_CR51","doi-asserted-by":"publisher","first-page":"106007","DOI":"10.1016\/j.bioorg.2022.106007","volume":"127","author":"Z Sang","year":"2022","unstructured":"Sang Z, Bai P, Ban Y, Wang K, Wu A, Mi J, Hu J, Xu R, Zhu G, Wang J, Zhang J, Wang C, Tan Z, Tang L (2022) Novel donepezil-chalcone-rivastigmine hybrids as potential multifunctional anti-Alzheimer\u2019s agents: Design, synthesis, in vitro biological evaluation, in vivo and in silico studies. Bioorg Chem 127:106007","journal-title":"Bioorg Chem"},{"key":"11733_CR52","doi-asserted-by":"crossref","unstructured":"Malik YA, Awad TA, Abdalla M, Yagi S, Alhazmi HA, Ahsan W, Albratty M, Najmi A, Muhammad S, Khalid A (2022) Chalcone scaffolds exhibiting acetylcholinesterase enzyme inhibition: mechanistic comput investigations. Molecules 27(10)","DOI":"10.3390\/molecules27103181"},{"issue":"12","key":"11733_CR53","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.2174\/1386207325666220214110717","volume":"25","author":"C Agoni","year":"2022","unstructured":"Agoni C, Issahaku AR, Abdelgawad MA, Khames A, Soliman MES, Mathew B (2022) Extended double bond conjugation in the chalcone framework favours mao-b inhibition: a structural perspective on molecular dynamics. Comb Chem High Throughput Screen 25(12):2059\u20132069","journal-title":"Comb Chem High Throughput Screen"},{"key":"11733_CR54","doi-asserted-by":"crossref","unstructured":"Gomes MN, Muratov EN, Pereira M, Peixoto JC, Rosseto LP, Cravo PVL, Andrade CH, Neves BJ (2017) Chalcone derivatives: promising starting points for drug design. Molecules 22(8)","DOI":"10.3390\/molecules22081210"},{"issue":"2","key":"11733_CR55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1021\/cc010048o","volume":"4","author":"A Lew","year":"2002","unstructured":"Lew A, Krutzik PO, Hart ME, Chamberlin AR (2002) Increasing rates of reaction: microwave-assisted organic synthesis for combinatorial chemistry. J Comb Chem 4(2):95\u2013105","journal-title":"J Comb Chem"},{"key":"11733_CR56","doi-asserted-by":"crossref","unstructured":"Rayees Ahmad M, Girija Sastry V, Bano N, Anwar S Synthesis of novel chalcone derivatives by conventional and microwave irradiation methods and their pharmacological activities. Arab J Chem 9","DOI":"10.1016\/j.arabjc.2011.09.002"},{"issue":"36","key":"11733_CR57","doi-asserted-by":"publisher","first-page":"12684","DOI":"10.1073\/pnas.0505975102","volume":"102","author":"L De Colibus","year":"2005","unstructured":"De Colibus L, Li M, Binda C, Lustig A, Edmondson DE, Mattevi A (2005) Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B. Proc Natl Acad Sci U S A 102(36):12684\u201312689","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"11733_CR58","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30(16):2785\u20132791","journal-title":"J Comput Chem"},{"issue":"24","key":"11733_CR59","doi-asserted-by":"publisher","first-page":"6362","DOI":"10.1016\/j.bmcl.2008.10.084","volume":"18","author":"V Jayaprakash","year":"2008","unstructured":"Jayaprakash V, Sinha BN, Ucar G, Ercan A (2008) Pyrazoline-based mycobactin analogues as MAO-inhibitors. Bioorg Med Chem Lett 18(24):6362\u20136368","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"11733_CR60","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bmcl.2009.11.015","volume":"20","author":"A Sahoo","year":"2010","unstructured":"Sahoo A, Yabanoglu S, Sinha BN, Ucar G, Basu A, Jayaprakash V (2010) Towards development of selective and reversible pyrazoline based MAO-inhibitors: synthesis, biological evaluation and docking studies. Bioorg Med Chem Lett 20(1):132\u2013136","journal-title":"Bioorg Med Chem Lett"},{"key":"11733_CR61","doi-asserted-by":"crossref","unstructured":"Case DA, Cheatham TE 3rd, Darden T, Gohlke H, Luo R, Merz KM Jr., Onufriev A, Simmerling C, Wang B, Woods RJ (2005) The Amber biomolecular simulation programs. J Comput Chem 26(16):1668\u20131688","DOI":"10.1002\/jcc.20290"},{"issue":"2","key":"11733_CR62","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/wcms.1121","volume":"3","author":"R Salomon-Ferrer","year":"2013","unstructured":"Salomon-Ferrer R, Case DA, Walker RC (2013) An overview of the Amber biomolecular simulation package. WIREs Comput Mol Sci 3(2):198\u2013210","journal-title":"WIREs Comput Mol Sci"},{"key":"11733_CR63","unstructured":"Amber 2024 Reference Manual (Covers Amber24 and AmberTools24). Available from: https:\/\/ambermd.org\/doc12\/Amber24.pdf"},{"issue":"9","key":"11733_CR64","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"BR Miller III","year":"2012","unstructured":"Miller BR III, McGee TD Jr., Swails JM, Homeyer N, Gohlke H, Roitberg AE (2012) MMPBSA.py: an efficient program for end-state free energy calculations. J Chem Theory Comput 8(9):3314\u20133321","journal-title":"J Chem Theory Comput"},{"issue":"2","key":"11733_CR65","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/prot.20033","volume":"55","author":"A Onufriev","year":"2004","unstructured":"Onufriev A, Bashford D, Case DA (2004) Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins Struct Funct Bioinform 55(2):383\u2013394","journal-title":"Proteins Struct Funct Bioinform"},{"issue":"1","key":"11733_CR66","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliver Rev 23(1):3\u201325","journal-title":"Adv Drug Deliver Rev"},{"issue":"1","key":"11733_CR67","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1021\/cc9800071","volume":"1","author":"AK Ghose","year":"1999","unstructured":"Ghose AK, Viswanadhan VN, Wendoloski JJ (1999) A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem 1(1):55\u201368","journal-title":"J Comb Chem"},{"issue":"W1","key":"11733_CR68","doi-asserted-by":"publisher","first-page":"W469","DOI":"10.1093\/nar\/gkae254","volume":"52","author":"Y Myung","year":"2024","unstructured":"Myung Y, de S\u00e1 AGC, Ascher DB (2024) Deep-PK: deep learning for small molecule pharmacokinetic and toxicity prediction. Nucleic Acids Res 52(W1):W469\u2013w475","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"11733_CR69","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1517\/17460441.2012.714363","volume":"7","author":"JA Arnott","year":"2012","unstructured":"Arnott JA, Planey SL (2012) The influence of lipophilicity in drug discovery and design. Expert Opin Drug Discov 7(10):863\u2013875","journal-title":"Expert Opin Drug Discov"},{"issue":"32","key":"11733_CR70","doi-asserted-by":"publisher","first-page":"24997","DOI":"10.1039\/C4RA15201H","volume":"5","author":"P-F Wang","year":"2015","unstructured":"Wang P-F, Qiu H-Y, Ma J-T, Yan X-Q, Gong H-B, Wang Z-C, Zhu H-L (2015) Dihydropyrazoles containing morpholine: design, synthesis and bioassay testing as potent antimicrobial agents. RSC Adv 5(32):24997\u201325005","journal-title":"RSC Adv"},{"key":"11733_CR71","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.phrs.2015.12.025","volume":"104","author":"H-Y Qiu","year":"2016","unstructured":"Qiu H-Y, Wang P-F, Li Z, Ma J-T, Wang X-M, Yang Y-H, Zhu H-L (2016) Synthesis of dihydropyrazole sulphonamide derivatives that act as anti-cancer agents through COX-2 inhibition. Pharmacol Res 104:86\u201396","journal-title":"Pharmacol Res"},{"key":"11733_CR72","doi-asserted-by":"publisher","first-page":"115610","DOI":"10.1016\/j.ejmech.2023.115610","volume":"258","author":"MA Shaldam","year":"2023","unstructured":"Shaldam MA, Hendrychova D, El-Haggar R, Vojackova V, Majrashi TA, Elkaeed EB, Masurier N, Krystof V, Tawfik HO, Eldehna WM (2023) 2,4-Diaryl-pyrimido[1,2-a]benzimidazole derivatives as novel anticancer agents endowed with potent anti-leukemia activity: synthesis, biological evaluation and kinase profiling. Eur J Med Chem 258:115610","journal-title":"Eur J Med Chem"},{"key":"11733_CR73","doi-asserted-by":"publisher","first-page":"111954","DOI":"10.1016\/j.ejmech.2019.111954","volume":"187","author":"D Elkhalifa","year":"2020","unstructured":"Elkhalifa D, Siddique AB, Qusa M, Cyprian FS, El Sayed K, Alali F, Al Moustafa A-E, Khalil A (2020) Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer. Eur J Med Chem 187:111954","journal-title":"Eur J Med Chem"},{"key":"11733_CR74","doi-asserted-by":"publisher","first-page":"103034","DOI":"10.1016\/j.bioorg.2019.103034","volume":"90","author":"E Polo","year":"2019","unstructured":"Polo E, Ibarra-Arellano N, Prent-Pe\u00f1aloza L, Morales-Bayuelo A, Henao J, Gald\u00e1mez A, Guti\u00e9rrez M (2019) Ultrasound-assisted synthesis of novel chalcone, heterochalcone and bis-chalcone derivatives and the evaluation of their antioxidant properties and as acetylcholinesterase inhibitors. Bioorg Chem 90:103034","journal-title":"Bioorg Chem"},{"issue":"19","key":"11733_CR75","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1016\/j.bmcl.2016.08.044","volume":"26","author":"HW Lee","year":"2016","unstructured":"Lee HW, Ryu HW, Kang MG, Park D, Oh SR, Kim H (2016) Potent selective monoamine oxidase B inhibition by maackiain, a pterocarpan from the roots of Sophora flavescens. Bioorg Med Chem Lett 26(19):4714\u20134719","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"11733_CR76","doi-asserted-by":"publisher","first-page":"21695","DOI":"10.1038\/s41598-020-78782-5","volume":"10","author":"JH Heo","year":"2020","unstructured":"Heo JH, Eom BH, Ryu HW, Kang M-G, Park JE, Kim D-Y, Kim J-H, Park D, Oh S-R, Kim H (2020) Acetylcholinesterase and butyrylcholinesterase inhibitory activities of khellactone coumarin derivatives isolated from Peucedanum japonicum Thurnberg. Sci Rep-Uk 10(1):21695","journal-title":"Sci Rep-Uk"},{"key":"11733_CR77","doi-asserted-by":"crossref","unstructured":"Jeong GS, Hillman PF, Kang MG, Hwang S, Park JE, Nam SJ, Park D, Kim H (2021) Potent and selective inhibitors of human monoamine Oxidase A from an endogenous lichen fungus diaporthe mahothocarpus. J Fungi (Basel) 7(10)","DOI":"10.3390\/jof7100876"},{"issue":"4","key":"11733_CR78","doi-asserted-by":"publisher","first-page":"785","DOI":"10.4014\/jmb.1612.12025","volume":"27","author":"HW Lee","year":"2017","unstructured":"Lee HW, Choi H, Nam SJ, Fenical W, Kim H (2017) Potent inhibition of monoamine Oxidase B by a piloquinone from marine-derived streptomyces sp. CNQ-027. J Microbiol Biotechnol 27(4):785\u2013790","journal-title":"J Microbiol Biotechnol"},{"issue":"W1","key":"11733_CR79","doi-asserted-by":"publisher","first-page":"W463","DOI":"10.1093\/nar\/gkaf361","volume":"53","author":"P Schake","year":"2025","unstructured":"Schake P, Bolz SN, Linnemann K, Schroeder M (2025) PLIP 2025: introducing protein-protein interactions to the protein-ligand interaction profiler. Nucleic Acids Res 53(W1):W463\u2013w465","journal-title":"Nucleic Acids Res"},{"key":"11733_CR80","doi-asserted-by":"crossref","unstructured":"Meng EC, Goddard TD, Pettersen EF, Couch GS, Pearson ZJ, Morris JH, Ferrin TE (2023) UCSF ChimeraX: Tools for structure building and analysis, Protein Sci 32(11) e4792","DOI":"10.1002\/pro.4792"},{"issue":"9","key":"11733_CR81","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA (2004) Development and testing of a general amber force field. J Comput Chem 25(9):1157\u20131174","journal-title":"J Comput Chem"},{"issue":"2","key":"11733_CR82","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jmgm.2005.12.005","volume":"25","author":"J Wang","year":"2006","unstructured":"Wang J, Wang W, Kollman PA, Case DA (2006) Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model 25(2):247\u2013260","journal-title":"J Mol Graph Model"},{"issue":"1","key":"11733_CR83","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","volume":"16","author":"C Tian","year":"2020","unstructured":"Tian C, Kasavajhala K, Belfon KAA, Raguette L, Huang H, Migues AN, Bickel J, Wang Y, Pincay J, Wu Q (2020) Simmerling, ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. J Chem Theory Comput 16(1):528\u2013552","journal-title":"J Chem Theory Comput"},{"issue":"9","key":"11733_CR84","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1021\/ct400314y","volume":"9","author":"R Salomon-Ferrer","year":"2013","unstructured":"Salomon-Ferrer R, G\u00f6tz AW, Poole D, Le Grand S, Walker RC (2013) Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh ewald. J Chem Theory Comput 9(9):3878\u20133888","journal-title":"J Chem Theory Comput"},{"issue":"7","key":"11733_CR85","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1021\/ct400341p","volume":"9","author":"DR Roe","year":"2013","unstructured":"Roe DR, Cheatham TE III (2013) Software for processing and analysis of molecular dynamics trajectory data. J Chem Theory Comput 9(7):3084\u20133095","journal-title":"J Chem Theory Comput"},{"key":"11733_CR86","unstructured":"Williams T, Kelley C Gnuplot-6.0.1: An Interactive Plotting Program, 2024. Available from: http:\/\/www.gnuplot.info\/"},{"issue":"13","key":"11733_CR87","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF Chimera\u2014A visualization system for exploratory research and analysis. J Comput Chem 25(13):1605\u20131612","journal-title":"J Comput Chem"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11733-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11733-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11733-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:03:02Z","timestamp":1793818982000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11733-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":87,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["11733"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11733-w","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"9 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}